GC
RDUS

Guggenheim Capital’s Radius Health, Inc. RDUS Stock Holding History

Guggenheim Capital’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-91,557
Closed -$1.63M – 2422
2018
Q3 		$1.63M Buy
91,557
+18,684
+26% +$423K 0.01% 1358
2018
Q2 		$2.15M Buy
72,873
+5,134
+8% +$162K 0.01% 1209
2018
Q1 		$2.44M Sell
67,739
-3,605
-5% -$130K 0.01% 1497
2017
Q4 		$2.27M Sell
71,344
-24,035
-25% -$754K 0.01% 1582
2017
Q3 		$3.68M Buy
95,379
+30,916
+48% +$1.21M 0.01% 1242
2017
Q2 		$2.92M Sell
64,463
-4,484
-7% -$171K 0.01% 1341
2017
Q1 		$2.67M Buy
68,947
+3,592
+5% +$151K 0.01% 1445
2016
Q4 		$2.48M Buy
65,355
+2,453
+4% +$117K 0.01% 1509
2016
Q3 		$3.4M Buy
+62,902
New +$3.2M 0.01% 1253
2016
Q2 		– Sell
-82,183
Closed -$2.58M – 2953
2016
Q1 		$2.58M Sell
82,183
-11,874
-13% -$411K 0.01% 1400
2015
Q4 		$5.79M Sell
94,057
-23,633
-20% -$1.49M 0.02% 949
2015
Q3 		$8.16M Sell
117,690
-8,960
-7% -$622K 0.03% 830
2015
Q2 		$8.57M Buy
126,650
+89,404
+240% +$4.16M 0.02% 907
2015
Q1 		$1.53M Buy
+37,246
New +$1.67M ﹤0.01% 1992

Other funds holding RDUS

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Guggenheim Capital's RDUS Position: Q4 2018 in Review

Guggenheim Capital sold out of Radius Health, Inc. (RDUS) in Q4 2018, closing a stake of 91,557 shares — an estimated $1.63M sold.

Guggenheim Capital first reported a position in RDUS in Q1 2015 and held it in 14 quarters. The position peaked at $8.57M in Q2 2015. 123 funds tracked by Wall St. Rank hold RDUS as of Q4 2018.

  • Guggenheim Capital reported no remaining Radius Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Guggenheim Capital sold 91,557 Radius Health, Inc. shares in Q4 2018, an estimated $1.63M.
  • Guggenheim Capital first reported a position in Radius Health, Inc. in Q1 2015 and held it in 14 quarters.
  • Guggenheim Capital's Radius Health, Inc. position peaked at $8.57M in Q2 2015.
  • 123 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2018.

Based on Guggenheim Capital's 13F filing for Q4 2018, filed 14 Feb 2019.